Sun Young Jung

Title: Spotlight on Inventor Sun Young Jung: Innovations in Crystalline Forms

Introduction: Sun Young Jung is a notable inventor based in Hwaseong-si, South Korea. With one patent to her name, she has made significant contributions to the field of pharmaceuticals. Her innovative work focuses on developing crystalline forms of a specific thienopyrimidine compound, which demonstrates promising applications in medicinal chemistry.

Latest Patents: Sun Young Jung holds a patent for the crystalline forms of N-(3-(2-(4-(4-methylpiperazin-1-yl)phenylamino)thieno[3,2-d]pyrimidin-4-yloxy)phenyl)acrylamide. This invention relates to pharmaceutical compositions that utilize these crystalline forms as active ingredients. The ease of use in preparing pharmaceutical compositions containing this compound enhances its significance in drug development and therapeutic applications.

Career Highlights: Sun Young Jung is associated with Hanmi Pharmaceutical Co., Ltd., where she has been instrumental in advancing research initiatives aimed at improving health outcomes through innovative drug formulations. Her work exemplifies the blend of scientific rigor and creativity necessary for successful invention in the highly competitive pharmaceutical industry.

Collaborations: Throughout her career, Sun Young Jung has collaborated with various esteemed colleagues, including Jae Hyuk Jung and Jong Ouk Baek. These partnerships have allowed her to expand her horizons and contribute even further to the field of pharmaceutical research.

Conclusion: Sun Young Jung’s innovative spirit and commitment to drug development underscore her role as a valuable inventor in the pharmaceutical sector. Her work with crystalline forms of thienopyrimidine compounds not only enhances medicinal compositions but also exemplifies the impact of collaboration in advancing scientific discoveries. As the pharmaceutical field continues to evolve, Jung's contributions will undoubtedly influence future innovations.